article thumbnail

PBMs and insurers want your prescription money

World of DTC Marketing

anti-kickback law that the drugmaker said prevented it from helping heart failure patients, many with low incomes, afford the medicine that costs $225,000 annually. For many, these coupons represent the difference between filling a prescription and going without lifesaving care, but there is a lot more here than just a co-pay coupon.

Insurance 226
article thumbnail

2022 Prescription Trends

PharmExec

The market for prescription medicines in the United States was subject to major shifts in use across therapeutic areas in 2022, reflecting changes in patient health needs, the development, and availability of novel medicines, and complex market dynamics.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

GoodRx Launches Solution To Help Consumers Manage Their Prescriptions

MedCity News

Medicine Cabinet, a new solution by GoodRx, gives users reminders to take their medications and refill prescriptions and recommends pharmacies based on prescription costs. It also has a rewards system for using GoodRx coupons and picking up prescriptions on time.

article thumbnail

A Prescription for Social Needs: Why Human Connection is Medicine

MedCity News

Weaving companionship into health care as we would a blockbuster drug can help us circumvent expensive healthcare services like emergency department visits and hospitalizations.

article thumbnail

The rise of prescription drug abuse and drug diversion

pharmaphorum

As prescription drug abuse has grown in the US and Europe, the diversion of such treatments from legitimate sources has also increased. Drug diversion is the channelling of prescription drugs from a medical source into the illegal market. The post The rise of prescription drug abuse and drug diversion appeared first on.

article thumbnail

UK approves prescription-only melatonin drug for childhood ADHD

Pharmaceutical Technology

The UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) has approved Colonis Pharma’s melatonin oral solution for the treatment of sleep-onset insomnia in children and adolescents with attention-deficit hyperactivity disorder (ADHD). Prescription-only vs OTC. Colonis Pharma is a subsidiary company within Clinigen.

article thumbnail

After similar moves in Kenya and India, GSK telegraphs commercial halt in Nigeria

Fierce Pharma

GSK said it plans to cease commercialization of its prescription medicines and vaccines in Nigeria, with the intent to switch to a third-party direct distribution model. After charting a similar move in Kenya last year, GSK is pulling the plug on its Nigerian operations. |